Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Archive of News

<< 2011 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2013 >>

24 May 2012: UCL, Intel and Imperial College London to create Global Centre for Research in Sustainable Connected Cities

UCL, Imperial College London and Intel have announced the launch of the Intel Collaborative Research Institute for Sustainable Connected Cities. More...

9 May 2012: UCL Wins Contract to Help Internationalise the Internet

UCL Arts & Humanities and UCL Consultants Ltd. have won a competitive bid to provide expertise to enable internet users to create full web addresses using non-Latin script names.
More...

<< 2011 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2013 >>